Funded Biotechnology Startups in United Kingdom
Across the 50 most recent disclosed biotechnology rounds in the United Kingdom, the largest disclosed amount is RQ Bio’s $113M on 2026-06-24.
Across the 50 most recent disclosed biotechnology rounds in the United Kingdom, the largest disclosed amount is RQ Bio’s $113M on 2026-06-24. That single figure dwarfs the rest of the disclosed rounds, where the next-largest disclosed amounts are $87M (Immutrin, 2026-03-24) and $83M (Cytospire Therapeutics, 2026-05-05). The list also shows a clear temporal clustering: 14 rounds fall between 2026-04-21 and 2026-05-07, including multiple seed and early-stage financings.
Stage and disclosure patterns are similarly uneven. “Series Unknown” appears in 25 of the 50 rows (with two additional rows marked “undisclosed” amounts: Harness Therapeutics on 2026-06-09 and Neurovalens on 2026-05-26). Pre-seed/Seed activity concentrates around late April to early May (e.g., Voxmind $740K on 2026-05-26; Northern Light Microscopy $1M on 2026-04-22; Five $6M and Scarlet Therapeutics $4M on 2026-05-07). Geographically, London-based companies repeat frequently across the most recent weeks (e.g., Concert Bio on 2026-06-29, RQ Bio on 2026-06-24, and Tharimmune not in London but multiple entries in London between 2026-04-21 and 2026-03-17), while the earliest row shown is Axovia Therapeutics on 2026-01-06 and the most recent date is 2026-06-30 (Biodexa Pharmaceuticals, $4M).
Most recent rounds
50 of 317267 more funded startups
This page shows the 50 most recent rounds (back to Jan 2026). The full 317-company history for this listing is available on a paid plan.
Unlock all 317 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
Which disclosed round is the outlier by size, and how does it compare with the rest of the disclosed amounts?
RQ Bio’s $113M round on 2026-06-24 is the only disclosed amount above $100M in these 50 rows. The next-largest disclosed rounds are $87M (Immutrin, 2026-03-24) and $83M (Cytospire Therapeutics, 2026-05-05), making RQ Bio’s figure meaningfully larger than the rest.
Do the rounds cluster into a specific recent time window, or are they evenly spread across the date range shown?
They cluster in late spring: there are 14 rounds between 2026-04-21 and 2026-05-07, including large financings like Cytospire Therapeutics $83M on 2026-05-05 and EnteroBiotix $26M on 2026-04-29. Outside that window, the list extends from 2026-01-06 (Axovia Therapeutics) to 2026-06-30 (Biodexa Pharmaceuticals).
What stage mix dominates, and how much of the dataset is not classified?
“Series Unknown” accounts for 25 of 50 rows, and “undisclosed” appears twice (Harness Therapeutics on 2026-06-09 and Neurovalens on 2026-05-26). When stages are specified, there is still visible early-stage activity around April–May, such as Northern Light Microscopy’s $1M pre-seed (2026-04-22) and Voxmind’s $740K pre-seed (2026-05-26).
Are there meaningful geographic concentrations in this list, especially around London?
London appears repeatedly across multiple weeks, including Concert Bio on 2026-06-29 ($130K), RQ Bio on 2026-06-24 ($113M), and R1 Therapeutics on 2026-03-17 ($78M). The list also shows other cities with multiple entries (e.g., Cambridge appears several times with rounds like CellCentric $220M on 2026-05-06 and Storm Therapeutics $56M on 2026-04-16).
Which entries are worth checking first if you focus on mid-to-large disclosed rounds rather than small seed checks?
Beyond the $113M outlier (RQ Bio, 2026-06-24), several disclosed rounds sit in the $50M–$87M band: CellCentric $220M is actually larger but it is also a major anchor (2026-05-06, $220M), while IMU Biosciences is $38M (2026-06-01) and Storm Therapeutics is $56M (2026-04-16). For contrast at the lower end, multiple pre-seed/seed rounds are under $2M, such as Axovia Therapeutics $1M (2026-01-06) and Corryn Biotechnologies $660K (2026-04-01).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.